Skip to content Accessibility statement

Cannabis dependency ‘wrongly labelled as a male issue’

News

Posted on Tuesday 22 October 2019

Research on cannabis dependency is wrongly skewed towards men, according to a new review.
Current evidence suggests that 1 in 10 cannabis users are at risk of developing cannabis dependence.

The review claims that questions currently included in the criteria for diagnosing cannabis dependency such as 'have you ever been intoxicated while driving a truck or operating machinery’ are an example of a bias towards identifying and treating men with the problem.

Research currently estimates that 12% of men who use cannabis compared with 5.5% of women are dependent on the drug, but gender bias means that women have been significantly undercounted in these estimates, the author says.

Risk of dependence

Ian Hamilton, from the Department of Health Sciences from the University of York, said: “Current evidence suggests that 1 in 10 cannabis users are at risk of developing cannabis dependence, but diagnostic criteria needs to be revised to ensure accurate representation of the problem.

“Male orientated questions set the criteria for cannabis abuse lower for men than women, so this could account for some of the difference between male and female dependence.

“We have a limited understanding of the impact that cannabis dependence has on women and the efficacy of treatment interventions for them.

“As a growing number of jurisdictions review their policies towards cannabis, many have opened up access to the drug for medicinal and/or recreational purposes. It is, therefore, important to consider what we know about the substance’s potential for creating dependence.”

Vulnerable and disadvantaged

The review argues that improving accuracy and confidence in cannabis dependence estimates should aid public health bodies in targeting and communicating with high-risk groups.

Ian Hamilton added: “Although most people will not be harmed by cannabis, those that are likely to be harmed will not be drawn equally from the population, as with problems associated with other drugs, they will be  some of the most vulnerable and disadvantaged in society. Problematic cannabis use like other drugs is just one disadvantage of many for these groups.”

Research newsletter

Our monthly research newsletter features a curated mix of news, events, and recent discoveries delivered straight to your inbox.

Sign up

Explore more news

News

16 November 2026

Researchers from the University of York will urge global action to tackle the growing threat of pharmaceuticals contaminating rivers and seas at a major United Nations conference in Geneva.

News

11 November 2026

The University of York and NatWest have unveiled a new Life Sciences Business Accelerator to turn academic breakthroughs into real-world health and environmental solutions.

News

10 November 2026

New research has shown that patients who receive care from both NHS and private hospitals need better protection against problems with quality and safety.

News

6 November 2026

The Minister for Science, Innovation and Investment, Chris McDonald MP, visited York’s historic Guildhall to learn how the University is driving economic growth and innovation across the region.

News

6 November 2026

The University of York has officially joined the UK Reproducibility Network (UKRN) as an institutional member, reinforcing its commitment to the highest standards of research rigour, transparency and inclusivity.

Read more news